Sharon Squazzo is an Applications and Business Development Scientist at Diagenode, Inc. Her responsibilities in this role encompass the technical development of Diagenode’s epigenomic product portfolio. Prior to joining Diagenode in 2010, Sharon was a Senior Research Associate in Dr. Peggy Farnham’s lab at the UC Davis Genome Center where she identified and characterized the mammalian gene targets of the transcriptional silencing complex PRC2 in embryonal and cancer cells using various epigenomic methods. Sharon received a B.S. degree in microbiology from the University of Massachusetts Amherst and has been working in the field of gene transcription and chromatin research for the past twenty years.